Sorrento Therapeutics Inc.

SRNE
$0.00 (- $0.00 - 16.67%)
Last updated: 2026-08-07 20:08 UTC
SRNE Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS83587F2020
CUSIP83587F202
Market Price0.0
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPSN/A
Market Cap$1.4M
Book Value-0.38
Price to Book-0.007
Beta1.0
52w High0.1
52w Low0.0
Next Earnings DateN/A

Sorrento Therapeutics Inc. trades under ticker SRNE on NASDAQ as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US83587F2020, CUSIP 83587F202. Also searched as Sorrento Therapeutics.

Related researchSRNE stock priceSRNE share priceSorrento Therapeutics stockSorrento Therapeutics share price83587F202
About the Company
Sorrento Therapeutics Inc. is a clinical and commercial stage biopharmaceutical company dedicated to developing innovative therapies for unmet medical needs. It focuses on cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases by leveraging proprietary technologies such as the G-MAB antibody library and targeted delivery modalities like CAR-T and DAR-T cell therapies. The company also develops pain management solutions, including resiniferatoxin and SEMDEXA, and has been involved in COVID-19 therapeutic and vaccine development. Sorrento Therapeutics operates across multiple sectors in the healthcare industry, contributing to advancements in biotechnology and pharmaceuticals.
Price History